Replies to post #513757 on NorthWest Biotherapeutics Inc (NWBO)

[HyGro]

FDA accepts 6 different endpoints for tumor replated cancers for application consideration. NWBO chose PFS and OS as endpoints. PFS was the primary endpoint. Please read the FDA's Guidance

https://www.fda.gov/media/71195/download on Tumor